New Zealand markets close in 2 hours 37 minutes

West Pharmaceutical Services, Inc. (WST)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
375.40-0.20 (-0.05%)
At close: 04:03PM EDT
383.95 +8.55 (+2.28%)
After hours: 06:47PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 27.74B
Enterprise value 27.26B
Trailing P/E 54.67
Forward P/E 42.55
PEG ratio (5-yr expected) 6.04
Price/sales (ttm)9.91
Price/book (mrq)10.10
Enterprise value/revenue 9.51
Enterprise value/EBITDA 36.68

Trading information

Stock price history

Beta (5Y monthly) 1.08
52-week change 352.44%
S&P500 52-week change 318.92%
52-week high 3415.73
52-week low 3206.19
50-day moving average 3389.07
200-day moving average 3335.69

Share statistics

Avg vol (3-month) 3338.48k
Avg vol (10-day) 3313.76k
Shares outstanding 573.86M
Implied shares outstanding 673.86M
Float 873.45M
% held by insiders 10.54%
% held by institutions 196.21%
Shares short (30 Aug 2023) 4916.92k
Short ratio (30 Aug 2023) 42.52
Short % of float (30 Aug 2023) 41.63%
Short % of shares outstanding (30 Aug 2023) 41.24%
Shares short (prior month 30 Jul 2023) 4617.14k

Dividends & splits

Forward annual dividend rate 40.76
Forward annual dividend yield 40.20%
Trailing annual dividend rate 30.75
Trailing annual dividend yield 30.20%
5-year average dividend yield 40.30
Payout ratio 410.92%
Dividend date 301 Aug 2023
Ex-dividend date 424 Jul 2023
Last split factor 22:1
Last split date 326 Sept 2013

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2022
Most-recent quarter (mrq)29 Jun 2023


Profit margin 18.10%
Operating margin (ttm)24.51%

Management effectiveness

Return on assets (ttm)12.49%
Return on equity (ttm)20.06%

Income statement

Revenue (ttm)2.87B
Revenue per share (ttm)38.52
Quarterly revenue growth (yoy)-2.30%
Gross profit (ttm)1.14B
Net income avi to common (ttm)518.7M
Diluted EPS (ttm)6.87
Quarterly earnings growth (yoy)-17.70%

Balance sheet

Total cash (mrq)796.3M
Total cash per share (mrq)10.78
Total debt (mrq)311.3M
Total debt/equity (mrq)11.33%
Current ratio (mrq)3.66
Book value per share (mrq)37.17

Cash flow statement

Operating cash flow (ttm)707M
Levered free cash flow (ttm)235.9M